Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized double-blind placebo controlled trial.

CM Black; AJ Silman; AL Herrick; CP Denton; H Wilson; J Newman; L Pompon; X. Shi-Wen

Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized double-blind placebo controlled trial.

CM Black, AJ Silman, AL Herrick, CP Denton, H Wilson, J Newman, L Pompon, X. Shi-Wen

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Arthritis & Rheumatism
Volume	42
Publication status	Published - 1999

Cite this

@article{9cb9a0616ca24c38804990a202c30628,

title = "Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized double-blind placebo controlled trial.",

author = "CM Black and AJ Silman and AL Herrick and CP Denton and H Wilson and J Newman and L Pompon and X. Shi-Wen",

year = "1999",

language = "English",

volume = "42",

journal = "Arthritis & Rheumatism",

issn = "1529-0131",

publisher = "John Wiley & Sons Ltd",

}

TY - JOUR

T1 - Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized double-blind placebo controlled trial.

AU - Black, CM

AU - Silman, AJ

AU - Herrick, AL

AU - Denton, CP

AU - Wilson, H

AU - Newman, J

AU - Pompon, L

AU - Shi-Wen, X.

PY - 1999

Y1 - 1999

M3 - Article

SN - 1529-0131

VL - 42

JO - Arthritis & Rheumatism

JF - Arthritis & Rheumatism

ER -